Keeping an Eye on ALLO, SYRS, PTGX, AUTL, and IMRA in Light of Biotech Catalysts; Disclosure Updates
Clinical data findings related to five SanaCurrents catalysts will be [...]
Xenon Pharmaceuticals (XENE) Probability Sentiment
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Probability Sentiment [...]
SanaCurrents holding BioCryst (BCRX) shares into December 3 PDUFA
The FDA will decide on December 3 whether to approve [...]
SanaCurrents closing out Adverum Biotechnologies (ADVM)
Adverum Biotechnologies (NASDAQ:ADVM) on Saturday reported positive results from its [...]
SanaCurrents Pivotal Sentiment on Protagonist (PTGX) polycythemia vera phase II trial
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Probability Sentiment [...]
Adverum catalyst set for Saturday, November 14
Adverum Biotechnologies (NASDAQ:ADVM) said it will present additional clinical data [...]
Calliditas’ Shares Soar About 35% After Hitting Catalyst
Sweden-based Calliditas Therapeutics’ (NASDAQ:CALT) delivered on its phase III trial [...]
SanaCurrents Advantageous Sentiment on Alimera Sciences, Inc. (ALIM) Revenue Growth
Alimera Sciences, Inc. (NASDAQ:ALIM) Probability Sentiment [...]